Background: In NOD mice, insulin B:9-23 peptide bound to I-Ag7 in an energy unfavorable register 3 (R3) forms the antigenic I-Ag7/B:9-23(R3) complex. Previously we demonstrated that I-Ag7/B:9-23(R3) specific monoclonal antibody mAb287 delayed T1D. Subsequent studies indicate that the IAg7/B:9-23(R3) complex contain two epitopes termed p8E and p8G epitopes. MAb287 binds to the p8E epitope but has a very low affinity to the p8G epitope. In the present study, we assessed whether a new antibody targeting both epitopes enhances disease protection efficacy.

Methods: We immunized young NOD mice with IAg7/B:9-23(R3) p8E and IAg7/B:9-23(R3) p8G proteins alternatively, and generated a new clone Ab757. We then tested the binding affinity of Ab757 to both epitopes and treated NOD mice with this antibody or control antibodies starting from the pre-insulitis or established-insulitis stages monitored the development of T1D.

Results: 1) MAb757 exhibits high binding affinity to both p8E and P8G epitopes, and it suppresses in vitro both p8E and p8G reactive T cells. 2). Compared to mAb287 targeting only one epitope, mAb757 shows significantly enhanced T1D protection. MAb757 injection protected 70% of recipient mice from diabetes (p<0.001 compared to control antibody treatment or mAb287) when treatment was initiated at 4 weeks (pre-insulitis) or 9 weeks of age (established insulitis stage). We previously reported that mAb287 conferred mild T1D protection (35%), but such weak protection was not observed in a repeated experiment. 3). MAb757 treatment significantly delayed the time and the severity of lymphocyte infiltrating islets assessed by immunocytochemical and flow cytometry analysis.

Conclusion: Bi-specific antibody treatment targeting two epitopes within the I-Ag7/B:9-23(R3) complex is a safe approach that significantly suppresses islet autoimmune responses and in turn protects mice from progressing to overt T1D.


J. Cepeda: None. N.S. Sekhar: None. J. Han: None. N. Zhang: None. M. Pietropaolo: None. L. Zhang: None.



Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at